1. AB0945 Secukinumab efficacy in patients with active psoriatic arthritis: pooled analysis of four phase 3 trials by prior anti-tnf therapy and concomitant methotrexate use. (12th June 2018) Authors: Kirkham, B.; Mease, P.J.; Nash, P.; Balsa, A.; Combe, B.; Rech, J.; Martin, R.; Ligozio, G.; Abrams, K.; Pricop, L. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB1089 Investigation of the efficacy and safety of secukinumab treatment in juvenile idiopathic arthritis subtypes of juvenile psoriatic and enthesitis-related arthritis: design of a randomised, double-blind, placebo controlled, multicenter study. (12th June 2018) Authors: Foell, D.; Veit, J.A.; Ilsley, E.; Abrams, K. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1654 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB1182 Efficacy and safety of canakinumab, fully human anti-interleukin-1beta antibody, in systemic juvenile idiopathic arthritis. (23rd January 2014) Authors: Ruperto, N.; Brunner, H.; Quartier, P.; Constantin, T.; Wulffraat, N.; Horneff, G.; Brik, R.; McCann, L.; Kasapcopur, O.; Rutkowska-Sak, L.; Schneider, R.; Berkun, Y.; Calvo, I.; Erguven, M.; Goffin, L.; Hofer, M.; Kallinich, T.; Knupp, S.; Uziel, Y.; Viola, S. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB1185 Sustained maintenance of adapted ACR pediatric response with canakinumab in patients with active systemic juvenile idiopathic arthritis. (23rd January 2014) Authors: Quartier, P.; Anton, J.; Barash, J.; Berner, R.; Abrams, K.; Lheritier, K.; Kim, D.; Wulffraat, N. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB1186 IL-1beta inhibition with canakinumab in patients with systemic juvenile idiopathic arthritis: Efficacy and safety outcomes from a single-dose, placebo-controlled study. (23rd January 2014) Authors: Quartier, P.; Erguven, M.; Horneff, G.; Berkun, Y.; Lheritier, K.; Kim, D.; Abrams, K.; Constantin, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Can illness beliefs, from the common-sense model, prospectively predict adherence to self-management behaviours? A systematic review and meta-analysis. Issue 8 (2nd August 2016) Authors: Aujla, N.; Walker, M.; Sprigg, N.; Abrams, K.; Massey, A.; Vedhara, K. Journal: Psychology & health Issue: Volume 31:Issue 8(2016) Page Start: 931 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0496 Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis with and Without Fever. (9th June 2015) Authors: Ruperto, N.; Brunner, H.; Quartier, P.; Constantin, T.; Alexeeva, E.; Kone-Paut, I.; Marzan, K.; Wulffraat, N.; Schneider, R.; Padeh, S.; Chasnyk, V.; Wouters, C.; Kummerle Deschner, J.; Kallinich, T.; Lauwerys, B.; Haddad, E.; Nasonov, E.; Trachana, M.; Vougiouka, O.; Abrams, K. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0528 Canakinumab in Systemic Juvenile Idiopathic Arthritis: Impact on the Rate and Clinical Presentation of Macrophage Activation Syndrome. (10th June 2014) Authors: Grom, A.A.; Brunner, H.I.; Ruperto, N.; Martini, A.; Lovell, D.; Pascual, V.; Lheritier, K.; Abrams, K.; Ilowite, N. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Further studies to evaluate methods of leucoreduction to prevent alloimmune platelet refractoriness and induce tolerance in a dog platelet transfusion model. Issue 1 (23rd March 2016) Authors: Slichter, S. J.; Abrams, K.; Bailey, S. Lawrence; Pellham, E.; Gettinger, I.; Christoffel, T.; Gaur, L.; Latchman, Y.; Nelson, K.; Bolgiano, D. Journal: Vox sanguinis Issue: Volume 111:Issue 1(2016) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0007 Changes in Gene Expression and Inflammatory Proteins in Systemic Juvenile Idiopathic Arthritis Patients on Canakinumab Therapy. (10th June 2014) Authors: Brachat, A.; Grom, A.; Wulffraat, N.; Brunner, H.; Quartier, P.; Brik, R.; McCann, L.; Ozdogan, H.; Rutkowska-Sak, L.; Schneider, R.; Gerloni, V.; Harel, L.; Terreri, M.; Houghton, K.; Joos, R.; Kingsbury, D.; Lopez-Benitez, J.; Bek, S.; Schumacher, M.; Valentin, M. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗